TriNet Insights Presents: Seven Deadly Sins of Life Sciences Entrepreneurship
WHO: Craig Shimasaki, Ph.D., MBA is president & CEO of Moleculera Labs, an autoimmune neurobiology company. He is a scientist and serial entrepreneur with over 32 years of biotechnology industry experience. In addition to co-founding three companies, he is the author and editor of two books – “The Business of Bioscience: What Goes into Making a Biotechnology Product” and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.” He is an adjunct professor at the University of Oklahoma, Price School of Business, where he teaches biotechnology entrepreneurship.
WHAT: The business decisions that biotech entrepreneurs make in the beginning may seem like the right thing to do at the time. However, these early decisions may not be the best foundation for long-term success.
In this free event, Dr. Shimasaki will share his experiences as an entrepreneur in the biotech industry. He will discuss the seven most common startup mistakes that life sciences leaders make and provide insight on how to recognize and repair these mistakes before time and capital run out.
Complimentary breakfast will be served.
WHEN: Wednesday, Sept. 14, 2016
8 a.m. – 10 a.m. ET
WHERE: Catalyst restaurant
300 Technology Square
Cambridge, MA 02139
REGISTER: RSVP here; space is limited.
Latest Press Releases
January 15, 2020
TriNet today announced that Shawn Guertin, prominent healthcare insurance executive, has been appointed to the Company’s Board of Directors.
January 15, 2020
TriNet today announced that Dr. Jacqueline Kosecoff, healthcare executive and industry veteran, has been appointed to the Company’s Board of Directors.
December 19, 2019
TriNet today announced that Katherine August-deWilde, a member of TriNet’s Board of Directors and Chair of the Compensation Committee, has been recognized as part of WomenInc.’s 2019 list of Most Influential Corporate Board Directors.